Acuva SOLARIX Passes Validation Testing against SARS-COV-2 (Covid-19)

We are excited to announce that the Acuva™ SOLARIX UV disinfecting wand has successfully obtained validation for a 99.9% disinfection rate against SARS-CoV-2 (COVID-19). The test report confirms the disinfection rate is achieved in under 10 seconds. Validation was conducted at a biosafety level 3 (BSL-3) lab certified by the United States Centers for Disease Control (CDC) to receive, handle, and use biological Select Agents. This lab conducts test and evaluation programs in the areas of infectious disease, drug development, and toxicology for a wide range of clients, including multiple departments within the US Government.

The SOLARIX wand, the first of a number of new innovations being developed by Acuva in response to the global pandemic, is a portable and rechargeable UV-LED disinfection device that fits in your pocket. It delivers powerful chemical-free disinfection performance which achieves an efficacy rate of >99.9% against viruses and bacteria, including all Coronaviruses. Using the SOLARIX device, users can safely disinfect high-touch non-porous surfaces.

The SOLARIX includes a number of features to ensure safe operation, including visible blue light mapping to indicate the area being disinfected. It opens to a wide 270-degree angle to allow for faster and easier disinfection of contoured and difficult to reach surfaces, in comparison to typical sanitizing practices and cleaning solutions. A built-in sensor prevents any accidental user hand exposure to UV. It also includes a built-in timer and a power button that requires double-click activation as a child-lock function.

The Acuva™ SOLARIX is available for purchase at www.acuvastore.com. For product inquiries, please visit www.acuvatech.com.

#acUVatech

©2021 Acuva Technologies Inc. All rights reserved.

Your Cart